Holocene Advisors’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Holocene Advisors’s Portfolio SILK Stock Details SILK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-31,155	Closed	-$1.29M	–	1040
2022 Q1	$1.29M	Buy	31,155 +2,155	+7%	+$75.8K	0.01%	645
2021 Q4	$1.24M	Sell	29,000 -15,322	-35%	-$767K	0.01%	644
2021 Q3	$2.44M	Sell	44,322 -6,734	-13%	-$352K	0.01%	501
2021 Q2	$2.44M	Sell	51,056 -12,785	-20%	-$651K	0.01%	518
2021 Q1	$3.23M	Buy	+63,841	New	+$3.55M	0.02%	481

Other funds holding SILK

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Holocene Advisors's SILK Position: Q2 2022 in Review

Holocene Advisors sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q2 2022, closing a stake of 31,155 shares — an estimated $1.29M sold.

Holocene Advisors first reported a position in SILK in Q1 2021 and held it in 5 quarters. The position peaked at $3.23M in Q1 2021. 139 funds tracked by Wall St. Rank hold SILK as of Q2 2022.

Holocene Advisors reported no remaining Silk Road Medical, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Holocene Advisors sold 31,155 Silk Road Medical, Inc. Common Stock shares in Q2 2022, an estimated $1.29M.
Holocene Advisors first reported a position in Silk Road Medical, Inc. Common Stock in Q1 2021 and held it in 5 quarters.
Holocene Advisors's Silk Road Medical, Inc. Common Stock position peaked at $3.23M in Q1 2021.
139 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q2 2022.

Based on Holocene Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.